Key result
The ANTHEM-HF study was designed to evaluate the safety and relationship between the site and intensity of autonomic regulation therapy and its effects on heart failure.
Why the study?
Does autonomic regulation therapy improve left ventricular function and symptoms in patients with LV dysfunction and chronic symptomatic heart failure?
Does autonomic regulation therapy improve left ventricular function and symptoms in patients with LV dysfunction and chronic symptomatic heart failure?
The ANTHEM-HF study is designed to evaluate the safety and efficacy of autonomic regulation therapy via vagus nerve stimulation in patients with heart failure and LV dysfunction.
No takes yet. Share an insight, caveat, or question.
Supports initial safety assessment of autonomic regulation therapy in HF; leaves open optimal site and intensity for efficacy trials.
DiCarlo et al. (2013) studied LV dysfunction and chronic symptomatic heart failure. Autonomic regulation therapy (ART) was evaluated. The ANTHEM-HF study was designed to evaluate the safety and relationship between the site and intensity of autonomic regulation therapy and its effects on heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: